Ocular Therapeutix OCUL stock price is down -21% in the last 5 days & volume is up over 500%, but can it bounce?

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

The official heat level for OCUL is, a 🔥1 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I established the coveted HOT Stock Reporting system.

To find out more about my story, CLICK HERE

[thrive_leads id=’28419′]

Ocular Therapeutix Company Information

Company Name: Ocular Therapeutix Inc.

Ticker: OCUL

Exchange: NASDAQ

Website: https://www.ocutx.com/

Ocular Therapeutix Company Summary:

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

OCUL stock price is due to News?

The U.S. Commercial Uptake of DEXTENZA.

• Net product revenue of DEXTENZA® for the quarter was $12.5 million, an 87% increase over the first quarter of 2021.
• In-market purchases were nearly 28,000 billable units for the quarter, with March accounting for approximately 10,500 billable units, setting a new record for a calendar month.

Compare Ocular Therapeutix OCUL stock Price vs Competitors

KalVista Pharmaceuticals KAVL HERE

Anika Therapeutics ANIK HERE

Trending Stock OCUL 5 Day Chart

OCUL Stock Price HOT Stock Grade:

OCUL is, a 🔥1 out of 4 . Here are my takeaways on it and why it is just a 1 out of 4. Hint, the financials are great and the news but it’s still a 1 of 4 because the chart is my primary KPI.

OCUL Trading Volume

The volume, the normal trading volume is established by the previous 30 days of trading and this stock is trading at an increase of 502% over the average. Normally, this indicates a higher demand in the stock or a sell off (selling pressure).

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

OCUL Technicals

The technical analysis “chart reading”, this stock is down 22% on the 5 day chart and the overall trend for the long term chart, the 1 month, is down 31%. INSERT ANNALYSIS

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

OCUL News Cycle

The news, there is significant news, “Net product revenue of DEXTENZA® for the quarter was $12.5 million, an 87% increase over the first quarter of 2021.”

OCUL Fundamentals

The fundamentals, how a company is doing financially can be a serious KPI and there is no exciting financial filings associated with this stock.

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

OCUL Awareness

Marketing efforts “Awareness Campaigns” Just like advertising a prroduct is important, advertising a publicly traded company during a news cycle is critical for the stock price of a company.

I have not found marketing efforts around the investor awareness of this company. So, I have awarded this stock a 1 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇

[thrive_leads id=’28419′]